HeimGEHC • NASDAQ
add
GE HealthCare Technologies Inc
61,48 $
Eftir lokun(0,00%)0,00
61,48 $
Lokað: 16. apr., 17:22:04 GMT-4 · USD · NASDAQ · Lagalegir fyrirvarar
Við síðustu lokun
63,10 $
Dagbil
60,70 $ - 63,70 $
Árabil
57,65 $ - 94,80 $
Markaðsvirði
28,15 ma. USD
Meðalmagn
5,00 m.
V/H-hlutf.
14,16
A/V-hlutfall
0,23%
Aðalkauphöll
NASDAQ
Í fréttum
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (USD) | des. 2024info | Breyting á/á |
|---|---|---|
Tekjur | 5,32 ma. | 2,17% |
Rekstrarkostnaður | 1,39 ma. | -4,07% |
Nettótekjur | 721,00 m. | 78,91% |
Hagnaðarhlutfall | 13,56 | 75,19% |
Hagnaður á hvern hlut | 1,45 | 22,88% |
EBITDA | 1,03 ma. | 20,42% |
Virkt skatthlutfall | 11,51% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (USD) | des. 2024info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 2,87 ma. | 15,20% |
Heildareignir | 33,09 ma. | 1,96% |
Heildarskuldir | 24,44 ma. | -2,81% |
Eigið fé alls | 8,65 ma. | — |
Útistandandi hlutabréf | 457,30 m. | — |
Eiginfjárgengi | 3,41 | — |
Arðsemi eigna | 6,62% | — |
Ávöxtun eigin fjár | 11,89% | — |
Peningaflæði
Breyting á handbæru fé
| (USD) | des. 2024info | Breyting á/á |
|---|---|---|
Nettótekjur | 721,00 m. | 78,91% |
Handbært fé frá rekstri | 913,00 m. | -13,05% |
Reiðufé frá fjárfestingum | -240,00 m. | -172,73% |
Reiðufé frá fjármögnun | -1,28 ma. | -41,89% |
Breyting á handbæru fé | -679,00 m. | -889,53% |
Frjálst peningaflæði | 1,05 ma. | 12,27% |
Um
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical Diagnostics, which manufactures contrast agents and radiopharmaceuticals.
The company's primary customers are hospitals and health networks. In 2023, the company received 42% of its revenue in the United States and 13% of its revenue from China, where the company faces increasing competition.
The company operates in more than 100 countries. GE Healthcare has major regional operations in Buc, France; Helsinki, Finland; Kraków, Poland; Budapest, Hungary; Yizhuang, China; Hino & Tokyo, Japan, and Bangalore, India. Its biggest R&D center is in Bangalore, India, built at a cost of $50 million. Wikipedia
Framkvæmdastjóri
Stofnsett
1994
Höfuðstöðvar
Vefsvæði
Starfsfólk
53.000
